T1	Disease 400 402	BC
#1	AnnotatorNotes T1	DOID:11054
T10	Disease 799 814	BC patients â‰¥T2
T11	Disease 829 831	BC
T15	Disease 1064 1066	BC
T17	Disease 1210 1212	BC
T19	Disease 1308 1314	cancer
#6	AnnotatorNotes T19	DOID:162
T3	Disease 486 488	BC
T5	Disease 559 561	BC
T7	Disease 717 719	BC
T2	RNA-Noncoding 386 396	miR-26a-5p
#10	AnnotatorNotes T2	family:1739
T4	Biomarker 444 482	miR-26a-5p was significantly increased
R1	Association Arg1:T4 Arg2:T3	
T6	RNA-Noncoding 444 454	miR-26a-5p
T8	RNA-Noncoding 512 522	miR-26a-5p
T9	Biomarker 512 551	miR-26a-5p expression was also elevated
R2	Association Arg1:T9 Arg2:T5	
T12	RNA-Noncoding 670 680	miR-26a-5p
T13	RNA-Noncoding 758 768	miR-26a-5p
T14	Biomarker 745 795	the level of miR-26a-5p was significantly enhanced
T16	RNA-Noncoding 885 895	miR-26a-5p
T18	Biomarker 844 901	G3 stage demonstrated much higher plasma miR-26a-5p level
T20	RNA-Noncoding 951 961	miR-26a-5p
R4	Association Arg1:T18 Arg2:T11	
T21	RNA-Noncoding 1033 1043	miR-26a-5p
T22	Biomarker 1033 1043	miR-26a-5p
R5	Association Arg1:T22 Arg2:T15	
T23	Biomarker 1153 1170	plasma miR-26a-5p
T24	RNA-Noncoding 1160 1170	miR-26a-5p
R6	Prognostic-Poor Arg1:T23 Arg2:T17	
T25	RNA-Noncoding 1256 1266	miR-26a-5p
T26	Biomarker 1249 1266	plasma miR-26a-5p
R7	Association Arg1:T26 Arg2:T19	
#2	AnnotatorNotes T22	C528163
R3	Association Arg1:T14 Arg2:T10	
